Vascular Risk Factors and Diabetic Neuropathy
Author(s) -
Solomon Tesfaye,
Nish Chaturvedi,
Simon E.M Eaton,
John D. Ward,
Christos Manes,
C Ionescu-Tîrgovişte,
Daniel R. Witte,
John Fuller
Publication year - 2005
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa032782
Subject(s) - medicine , diabetes mellitus , diabetic neuropathy , glycemic , risk factor , prospective cohort study , surgery , endocrinology
Other than glycemic control, there are no treatments for diabetic neuropathy. Thus, identifying potentially modifiable risk factors for neuropathy is crucial. We studied risk factors for the development of distal symmetric neuropathy in 1172 patients with type 1 diabetes mellitus from 31 centers participating in the European Diabetes (EURODIAB) Prospective Complications Study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom